Fast Track Initiative β 2026 Investments
3 investments dated 2026 Β· listed companies and verified rows first Β· show all
Qoly Corporation develops, manufactures, and sells microsurgery-assist robots and related products, using robotics to help surgeons perform precise and safe microsurgery for functional disorders.
HealthtechMedical DevicesRoboticsTokyo, JP
Yohei Kuroda(Representative Director & President (Co-founder))inKazuhito Wakana(Director & CTO (Co-founder))Atsushi Miyamoto(Chief People Officer (Co-founder))Naoki Kobayashi(CFO)
Co-investorsDevelopment Bank of JapanMedVenture Partners, Inc.
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalM VenturesPfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.+1 more
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.